ARCHIVES

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

This article is from The Cancer Letter archive.

Vol. 32 No. 43 | December 1, 2006

Download PDF Visit The Full Archive

Related Articles

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

Salick Signs contract for Fixed-Price Oncology Services

April 1, 1994

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

Congress Passes Biomedical Research Authorization, Regular Appropriations Bill; NCI Gets $1.183 Billion

October 19, 1984

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012